Previous 10 | Next 10 |
The June Federal Reserve meeting has concluded, and the stock market has responded. Investors and traders alike have begun positioning themselves based on the latest commentary from Jerome Powell’s FOMC press conference. The interesting part about this is that some stocks don’...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Akebia Therapeutics (NASDAQ: AKBA ) stock leads our winners on heavy trading. 180 Life Sciences (NASDAQ: ATNF ) stock tops our losers on regulator responses. Plenty of penny stocks are on the move this morn...
Announcing initial Phase 1 data for its radionuclide therapy FAP-2286 in solid tumors, Clovis Oncology (NASDAQ:CLVS) said on Tuesday that one patient out of nine treated with the experimental therapy developed a confirmed partial response. The Phase 1 portion of the Phase 1/2 LuMIERE study is...
First presentation of initial LuMIERE Phase 1 data demonstrated a manageable safety profile with preliminary evidence of activity Nine patients treated to date with 177 Lu-FAP-2286 up to 5.5 GBq/dose No serious adverse events, treatment discontinuations, deaths o...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Day One Biopharmaceuticals ( DAWN ) stock is gaining on Tuesday despite stock offering news. This is likely due to positive clinical trial results from Monday. The company’s stock is experiencing heavy tra...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Continental Resources ( CLR ) stock is moving on a takeover offer from Harold Hamm. He’s offering $70 in cash for each share of CLR. Hamm is the founder of Continental Resources back when it went by Shelly...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Clovis Oncology (NASDAQ: CLVS ) are up 25% today on rumors that the cancer treatment company could be acquired by pharmaceutical giant Sanofi (NASDAQ: SNY ). The movement in CLVS stock is largely being...
Buying Penny Stocks on June 14th? Here’s What You Need to Know If you’re looking for penny stocks to buy right now, there are plenty of options to choose from. In June 2022 stocks are highly dependent on rising inflation and interest rates from the Fed. And because of that...
At 2022 Russell indexes annual reconstitution, following notable health care stocks will be added to and deleted from the Russell 3000 Index. Notable additions: Clover Health Investments (CLOV), Aurinia Pharmaceuticals (AUPH), Nano-X Imaging (NNOX), ADMA Biologics (ADMA),&...
Penny stocks are great tools to make money in the stock market. While they don’t come without risk, there are plenty of ways to ensure you find the top names to watch. One of the first steps is looking for specific catalysts. These could be anything from unusual trading activity to m...
News, Short Squeeze, Breakout and More Instantly...
Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., E...